domingo, 19 de mayo de 2019

By setting data standards, the FDA can revolutionize research - STAT

By setting data standards, the FDA can revolutionize research - STAT

First Opinion

Two words to help Ned Sharpless revolutionize clinical trials: data standards

By SAM VOLCHENBOUM


DANIEL SONE/NATIONAL CANCER INSTITUTE
By making data standards a priority, the FDA would transform clinical trials and create better ways to see how drugs affect patients.

No hay comentarios: